Atkinson-Clement, C., et al. (2017). Diffusion tensor imaging in Parkinson’s disease: Review and meta-analysis. NeuroImage: Clinical, 16, 98–110.
Banwinkler, M., et al. (2022). Imaging the limbic system in Parkinson’s disease-A review of limbic pathology and clinical symptoms. Brain Science, 12(9), 1248.
Barrett, M. J., et al. (2021). Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson disease. Parkinsonism & Related Disorders, 90, 27–32.
Bayoumi, A., et al. (2023). Identifying the white matter pathways involved in multiple sclerosis-related tremor using diffusion tensor imaging. Multiple Sclerosis Journal – Experimental, Translational and Clinical, 9(4), 20552173231208270.
Campabadal, A., et al. (2017). Brain correlates of progressive olfactory loss in Parkinson’s disease. Parkinsonism & Related Disorders, 41, 44–50.
Casjens, S., et al. (2013). Diagnostic value of the impairment of olfaction in Parkinson’s disease. PLoS ONE, 8(5), e64735.
Doty, R. L. (2012). Olfactory dysfunction in Parkinson disease. Nature Reviews Neurology, 8(6), 329–339.
Ercoli, T., et al. (2022). Does olfactory dysfunction correlate with disease progression in Parkinson’s disease? A systematic review of the current literature. Brain Sciences, 12(5), 513.
Fang, T.-C., et al. (2021). The association of olfactory dysfunction with depression, cognition, and disease severity in Parkinson’s disease. Frontiers in Neurology, 12, 779712.
Faskowitz, J., Betzel, R. F., & Sporns, O. (2022). Edges in brain networks: Contributions to models of structure and function. Network Neuroscience, 6(1), 1–28.
Fu, Y., et al. (2022). Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease. Acta Neuropathologica, 144(5), 861–879.
Fullard, M. E., Morley, J. F., & Duda, J. E. (2017). Olfactory dysfunction as an early biomarker in Parkinson’s disease. Neuroscience Bulletin, 33(5), 515–525.
Georgiopoulos, C., et al. (2017). Olfactory impairment in Parkinson’s disease studied with diffusion tensor and magnetization transfer imaging. Journal of Parkinson’s Disease, 7(2), 301–311.
Haehner, A., et al. (2009). Prevalence of smell loss in Parkinson’s disease – A multicenter study. Parkinsonism & Related Disorders, 15(7), 490–494.
Haehner, A., et al. (2018). Substantia nigra fractional anisotropy changes confirm the PD at-risk status of patients with idiopathic smell loss. Parkinsonism & Related Disorders, 50, 113–116.
Haghshomar, M., et al. (2018). Disruption of inferior longitudinal fasciculus microstructure in Parkinson’s disease: A systematic review of diffusion tensor imaging studies. Frontiers in Neurology, 9, 598.
He, R., et al. (2020). Olfactory dysfunction predicts disease progression in Parkinson’s disease: A longitudinal study. Frontiers in Neuroscience, 14, 569777.
Herzog, R., et al. (2013). Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review. BMC Public Health, 13(1), 154.
Holmes, S. E., et al. (2024). Synaptic loss and its association with symptom severity in Parkinson’s disease. NPJ Parkinsons disease, 10(1), 42.
Hussein, A., et al. (2023). Non-motor symptoms of Parkinson’s disease: The neurobiology of early psychiatric and cognitive dysfunction. The Neuroscientist, 29(1), 97–116.
Hwang, E. J., et al. (2019). Magnetic resonance imaging assessment of the substrate for hyposmia in patients with Parkinson’s disease. Clinical Radiology, 74(6), 489.e9-489.e15.
Ibarretxe-Bilbao, N., et al. (2010). Olfactory impairment in Parkinson’s disease and white matter abnormalities in central olfactory areas: A voxel-based diffusion tensor imaging study. Movement Disorders, 25(12), 1888–1894.
Kamali, A., et al. (2023). The cortico-limbo-thalamo-cortical circuits: An update to the original papez circuit of the human limbic system. Brain Topography, 36(3), 371–389.
Kapogiannis, D., et al. (2011). Reward processing abnormalities in Parkinson’s disease. Movement Disorders, 26(8), 1451–1457.
Kinger, S. B., et al. (2023). Changes in apathy, depression, and anxiety in Parkinson’s disease from before to during the COVID-19 era. Brain Science, 13(2), 199.
Lee, J. J., et al. (2016). Optic nerve integrity as a visuospatial cognitive predictor in Parkinson’s disease. Parkinsonism and Related Disorders, 31, 41–45.
Leon, M., & Woo, C. C. (2022). Olfactory loss is a predisposing factor for depression, while olfactory enrichment is an effective treatment for depression. Frontiers in Neuroscience, 16, 1013363.
Liberati, A., et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine, 6(7), e1000100.
Linortner, P., et al. (2020). White matter hyperintensities related to Parkinson’s disease executive function. Movement Disorders Clinical Practice, 7(6), 629–638.
Lo, C. K., Mertz, D., & Loeb, M. (2014). Newcastle-Ottawa Scale: Comparing reviewers’ to authors’ assessments. BMC Medical Research Methodology, 14, 45.
Mainland, J. D., et al. (2005). Olfactory impairments in patients with unilateral cerebellar lesions are selective to inputs from the contralesional nostril. Journal of Neuroscience, 25(27), 6362–6371.
Naafs, J. C., et al. (2020). Cognitive outcome in congenital central hypothyroidism: A systematic review with meta-analysis of individual patient data. European Journal of Endocrinology, 182(3), 351–361.
Nabizadeh, F., Pirahesh, K., & Khalili, E. (2022). Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s disease. Neurological Sciences, 43(7), 4193–4201.
Nakhostin-Ansari, A., et al. (2021). Effects of pulsed ultrasound on olfactory dysfunction in patients with chronic rhinosinusitis: A pilot study. Complementary Therapies in Clinical Practice, 44, 101409.
Oppo, V., et al. (2020). “Smelling and Tasting” Parkinson’s disease: Using senses to improve the knowledge of the disease. Front Aging Neurosci, 12, 43.
Pimer, L. J., et al. (2023). Aberrant corticospinal tract characteristics in prodromal PD: A diffusion tensor imaging study. Clinical Parkinsonism and Related Disorders, 8, 100182.
Poewe, W., et al. (2017). Parkinson disease. Nature Reviews Disease Primers, 3(1), 1–21.
Pourahmad, R., et al. (2023). Deep brain stimulation (DBS) as a therapeutic approach in gait disorders: What does it bring to the table? IBRO Neuroscience Reports, 14, 507–513.
Pujol, S. (2015). Chapter 4 - imaging white matter anatomy for brain tumor surgery. In A. J. Golby (Ed.), Image-guided neurosurgery (pp. 91–121). Academic Press.
Rolls, E. T. (2019). The cingulate cortex and limbic systems for emotion, action, and memory. Brain Structure and Function, 224(9), 3001–3018.
SanjariMoghaddam, H., et al. (2019). Association of olfaction dysfunction with brain microstructure in prodromal Parkinson disease. Neurological Sciences, 40(2), 283–291.
Sasaki, S., & Horie, Y. (2020). Association between olfactory impairment and disease severity and duration in Parkinson’s disease. Movement Disorders Clinical Practice, 7(7), 820–826.
Schäfer, L., Schriever, V. A., & Croy, I. (2021). Human olfactory dysfunction: Causes and consequences. Cell and Tissue Research, 383(1), 569–579.
Seyedmirzaei, H., et al. (2023). Neurite orientation dispersion and density imaging in multiple sclerosis: A systematic review. Journal of Magnetic Resonance Imaging, 58(4), 1011–1029.
Sobhani, S., et al. (2019). Exploring white matter microstructure and olfaction dysfunction in early parkinson disease: Diffusion MRI reveals new insight. Brain Imaging and Behavior, 13(1), 210–219.
Vaswani, P. A., et al. (2022). Serial olfactory testing for the diagnosis of prodromal Parkinson’s disease in the PARS study. Parkinsonism & Related Disorders, 104, 15–20.
Wang, J., et al. (2011). Association of olfactory bulb volume and olfactory sulcus depth with olfactory function in patients with Parkinson disease. American Journal of Neuroradiology, 32(4), 677–681.
Wattendorf, E., et al. (2009). Olfactory impairment predicts brain atrophy in Parkinson’s disease. Journal of Neuroscience, 29(49), 15410–15413.
Weber, B., Fliessbach, K., & Elger, C. E. (2009). IMAGING | magnetic resonance imaging in epilepsy research: Recent and upcoming developments. In P. A. Schwartzkroin (Ed.), Encyclopedia of basic epilepsy research (pp. 1549–1554). Academic Press.
Wells, G., et al. (2000).The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. https://www.researchgate.net/publication/261773681_The_Newcastle-Ottawa_Scale_NOS_for_Assessing_the_Quality_of_Non-Randomized_Studies_in_Meta-Analysis
Wen, M. C., et al. (2017a). Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson’s disease. Scientific Reports, 7(1), 1559.
Wen, M. C., et al. (2017b). Structural connectome alterations in prodromal and de novo Parkinson’s disease patients. Parkinsonism and Related Disorders, 45, 21–27.
Yang, K., et al. (2023). White matter changes in Parkinson’s disease. npj Parkinson’s Disease, 9(1), 150.
Yoneyama, N., et al. (2018). Severe hyposmia and aberrant functional connectivity in cognitively normal Parkinson’s disease. PLoS ONE, 13(1), e0190072.
Yuki, N., et al. (2020). Visual hallucinations and inferior longitudinal fasciculus in Parkinson’s disease. Brain and Behavior: A Cognitive Neuroscience Perspective, 10(12), e01883.
Zhang, K., et al. (2011). Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson’s disease. European Journal of Radiology, 77(2), 269–273.
留言 (0)